Web Analytics

3 Latest Announced Rounds

$1,218.03M Raised in 67 Funding Rounds in the past 7 Days - View All

Funding Round Profile

MSInsight

start up
France - Paris
  • 11/03/2025
  • Seed
  • $1,735,762

MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.

MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.

We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.


Related People

Arnaud CutivetFounder

Arnaud Cutivet France - Lyon, Auvergne-Rhône-Alpes

N/A